CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 189 enrolled
Drug / intervention
SyMRI 15 (3D)device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05425927
NCT05425927N/ACompleted
CompareCT.gov

Validation of 3D Synthetic MRI for Neuroimaging - Prospective, Multicenter, Multireader Investigation

SyntheticMR·interventional·Posted Jun 21, 2022·Updated Apr 23, 2025

In Brief

A clinical study evaluating SyMRI 15 (3D) for Clinical Indication for Brain MRI and Healthy Volunteers. Completed, enrolled 189 participants across 6 sites.

Detailed Summary

This study is being conducted for evaluation of 3D Synthetic MRI (SyMRI 15, 3D) for neuroimaging,

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsClinical Indication for Brain MRI, Healthy Volunteers
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2023202420252026
First PostedJun 21, 2022
Enrollment StartJun 27, 2022
Primary CompletionFeb 10, 2024
Study CompletionJul 31, 2024
TodayJul 2, 2026
Enrollment to primary: 1.6 yearsPosted 4.0 years ago

Interventions

SyMRI 15 (3D)device

Neurological MRI image collection